Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sumitomo to transfer Calsed sales to Nippon Kayaku

Jan. 20, 2005

Clinical data suggests perifosine may be effective in sarcoma

Jan. 20, 2005

University of Pennsylvania scientists patent new methods for the treatment of cancer

Jan. 19, 2005

New compositions for cancer diagnosis and therapy

Jan. 19, 2005

Novel antimitotic compounds in early development at Cytokinetics

Jan. 19, 2005

Enrollment complete in phase I study of Davanat/5-FU

Jan. 19, 2005

Melanocortin-4 receptor antagonist potentially useful for the treatment of cachexia

Jan. 19, 2005

A specific inhibitor of Akt shows antitumor activity and low toxicity in rodents

Jan. 19, 2005

Agents for the treatment of proliferative disorders described in patent literature

Jan. 18, 2005

BAY-43-9006 studied for pancreatic cancer in NCI-sponsored phase II study

Jan. 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...